BioCorRx (BICX) Non-Current Debt (2013 - 2026)

BioCorRx has disclosed Non-Current Debt across 10 years of filings, most recently posting $69155.0 for Q1 2026.

• Non-Current Debt for Q1 2026 came in at $69155.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $69155.0 (changed N/A YoY), and the FY2025 annual result was $69537.0, down 2.1% from the prior year.
• Non-Current Debt came in at $69155.0 for Q1 2026 at BioCorRx, down from $69537.0 in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $73850.0 in Q4 2022 to a low of $69155.0 in Q1 2026.
• The 4-year median for Non-Current Debt is $69803.0 (2025), against an average of $70674.8.
• Across the five-year window, Non-Current Debt declined 0.61% in 2022 and slipped 2.1% in 2025, its largest moves.
• BioCorRx's Non-Current Debt stood at $73850.0 in 2022, then slipped by 3.82% to $71029.0 in 2024, then declined by 2.1% to $69537.0 in 2025, then dropped by 0.55% to $69155.0 in 2026.
• The last three Non-Current Debt figures came in at $69155.0 (Q1 2026), $69537.0 (Q4 2025), and $69803.0 (Q3 2025), per Business Quant data.